BiOptic (ROCO:6850) Cash Flow for Dividends: NT$0.0 Mil (TTM As of Dec. 2025)


ROCO:6850 BiOptic Inc ROCO:6850
92 GF Score
Price NT$34.25
GF Value NT$44.90
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is BiOptic Cash Flow for Dividends?

BiOptic ROCO:6850 +0.74% 92 Cash Flow for Dividends is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:6850 with a GF Score™ of 92/100 and a GF Value™ of NT$44.90 (Modestly Undervalued). The stock has 4 warning signs investors should review.

BiOptic's cash flow for dividends for the six months ended in Dec. 2025 was NT$0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

BiOptic's annual payment of dividends declined from Dec. 2023 (NT$-24.2 Mil) to Dec. 2024 (NT$-5.3 Mil) but then increased from Dec. 2024 (NT$-5.3 Mil) to Dec. 2025 (NT$-9.0 Mil).

BiOptic Cash Flow for Dividends Related Terms

BiOptic Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for BiOptic's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BiOptic Cash Flow for Dividends Chart

BiOptic Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial 0.00 -11.00 -24.20 -5.32 -9.02

BiOptic Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6850
92GF Score
BiOptic Inc ROCO:6850
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BiOptic Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of NT$0.0 Mil mean?
BiOptic (ROCO:6850) has a Cash Flow for Dividends of NT$0.0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for BiOptic and its competitors.
Is BiOptic's Cash Flow for Dividends too high?
BiOptic's current Cash Flow for Dividends is NT$0.0 Mil. Overall, BiOptic has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BiOptic's Cash Flow for Dividends compare to VRTX and REGN?
BiOptic's Cash Flow for Dividends of NT$0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for BiOptic and its competitors. BiOptic's current Cash Flow for Dividends is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BiOptic stock overvalued right now?
Based on GuruFocus' analysis, BiOptic (ROCO:6850) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$44.90, compared to a current price of NT$34.25 — trading 23.7% below its estimated fair value. The current Cash Flow for Dividends is NT$0.0 Mil. BiOptic's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For BiOptic (ROCO:6850), the current Cash Flow for Dividends is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BiOptic (ROCO:6850) Overvalued in 2026?

Based on GuruFocus' analysis, BiOptic stock appears to be undervalued. The current stock price of NT$34.25 is trading 23.7% below its estimated GF Value™ of NT$44.90. GuruFocus considers BiOptic to be Modestly Undervalued.

Key valuation signals for ROCO:6850:

  • Cash Flow for Dividends: NT$0.0 Mil
  • GF Value™: NT$44.90 vs. price of NT$34.25 (23.7% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6850 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BiOptic Business Description

Address No. 108-3, Minquan Road, 4th Floor, Xindian District, New Taipei, TWN, 23141
BiOptic Inc is a biotechnology instrumentation company that develops scientific products for research and clinical applications. It serves professionals and laboratories dedicated to life science research, clinical diagnostics, pharmaceutical and food industries, animal husbandry, and agriculture, performing diagnostic molecular genetic analyses.
92GF Score

Get the complete analysis for ROCO:6850

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.25
Price
NT$44.90
GF Value